zinforo
pfizer ireland pharmaceuticals - ceftarolino fosamilis - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials sisteminio naudojimo, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
xofluza
roche registration gmbh - baloxavir marboxil - gripas, žmogus - antivirusiniai vaistai sisteminiam naudojimui - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.
monkasta
krka, d.d., novo mesto - montelukastas - plėvele dengtos tabletės - 10 mg; 5 mg; 4 mg - montelukast
montelukast accord
accord healthcare b.v. - montelukastas - kramtomosios tabletės - 4 mg; 5 mg - montelukast
montelukast aurobindo
aurobindo pharma (malta) limited - montelukastas - kramtomosios tabletės - 5 mg; 4 mg - montelukast
montelukast fair-med
fair-med healthcare gmbh - montelukastas - plėvele dengtos tabletės - 5 mg; 4 mg; 10 mg - montelukast
montelukast orion
orion corporation - montelukastas - tabletės - 10 mg; 4 mg; 5 mg - montelukast
montelukast torrent
torrent pharma gmbh - montelukastas - tabletės - 10 mg; 5 mg; 4 mg - montelukast
serevent diskus
glaxosmithkline trading services limited - salmeterolis - dozuoti įkvepiamieji milteliai - 50 µg/dozėje - salmeterol